3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumors
4
Advanced Solid Tumors
4
Solid Tumor
3
Mesothelioma
3
Advanced Solid Tumor
3
Advanced Solid Tumours
2
Thymoma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Malignant Solid Tumors
1
Lung Neoplasms
1
Advanced Solid Tumor, Adult
1
Advanced Cancer
1
Interventions
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Solid Tumor, Adult
×
olaparib
×
Other solid neoplasm
×
Clear all
NCT04972110
2025-10-30
ATTACC
Repare Therapeutics
Phase 1/2
Terminated
156 enrolled
19 charts